Vista previa | Fecha de publicación | Título | Autor(es) | Acceso |
![Codeine and Tramadol use in athletes A potential for abuse.pdf.jpg](/retrieve/a8be4457-c089-4e2d-ba0c-38e2eebabfba/Codeine%20and%20Tramadol%20use%20in%20athletes%20A%20potential%20for%20abuse.pdf.jpg) | jun-2021 | Codeine and Tramadol Use in Athletes: A Potential for Abuse | Zandonai, Thomas; Escorial, Mónica; Peiró, Ana | ![](/image/openAccess.png) |
![Sex Differences in Opioid Response Linked to OPRM1 and COMT genes DNA Methylation-Genotypes Changes in Patients with Chronic Pain.pdf.jpg](/retrieve/ea9a64a5-72c7-4efd-b163-0458923f5c5e/Sex%20Differences%20in%20Opioid%20Response%20Linked%20to%20OPRM1%20and%20COMT%20genes%20DNA%20Methylation-Genotypes%20Changes%20in%20Patients%20with%20Chronic%20Pain.pdf.jpg) | 13-may-2023 | Sex Differences in Opioid Response Linked to OPRM1 and COMT genes DNA Methylation/Genotypes Changes in Patients with Chronic Pain | Agulló, Laura; Muriel, Javier; Margarit, César; Escorial, Mónica; Garcia, Diana; Herrero, María José; Hervás, David; Sandoval, Juan; Peiró, Ana | ![](/image/openAccess.png) |
![Clinical prediction of opioid use disorder in chronic pain patients. A cohort-retrospective study with a pharmacogenetic approach.pdf.jpg](/retrieve/a558ddfe-37b5-4dd4-8872-0167dd3ecf23/Clinical%20prediction%20of%20opioid%20use%20disorder%20in%20chronic%20pain%20patients.%20A%20cohort-retrospective%20study%20with%20a%20pharmacogenetic%20approach.pdf.jpg) | 12-abr-2024 | Clinical prediction of opioid use disorder in chronic pain patients: a cohort-retrospective study with a pharmacogenetic approach | Escorial, Mónica; Muriel, Javier; Agulló, Laura; Zandonai, Thomas; Margarit, César; Morales, Domingo; Peiró, Ana | ![](/image/openAccess.png) |
![Oxycodonenaloxone - naloxone versus tapentadol in real-world chronic non-cancer pain management.an observational and pharmacogenetic study.pdf.jpg](/retrieve/49e3f51c-59c2-43d1-9d15-6d348e3d5cf2/Oxycodonenaloxone%20-%20naloxone%20versus%20tapentadol%20in%20real-world%20chronic%20non-cancer%20pain%20management.an%20observational%20and%20pharmacogenetic%20study.pdf.jpg) | jun-2022 | Oxycodone/naloxone versus tapentadol in real-world chronic non-cancer pain management: an observational and pharmacogenetic study | Barrachina, Jordi; Margarit, César; Muriel, Javier; López‑Gil, Santiago; López Gil, Vicente; Vara-González, Amaya; Planelles, Beatriz; Inda, María del Mar; Morales, Domingo; Peiró, Ana | ![](/image/openAccess.png) |
![Association between chronic pain medications.pdf.jpg](/retrieve/d3b43b36-3681-43bf-8658-45f8cb5d5815/Association%20between%20chronic%20pain%20medications.pdf.jpg) | jul-2021 | Association between chronic pain medications and the severity and mortality of COVID-19: Study protocol for a case-population study | Serrano Afonso, Ancor; Pérez hernández, Concepción; Ochoa Mazarro, Dolores; Román Martínez, Manuel; Failde Martínez, Inmaculada; Montes Pérez, Antonio; López Pais, Pablo; Cánovas Martínez, Luz; Revuelta Rizo, Miren; Padilla del Rey, María Luz; Peiró, Ana; Aberasturi Fueyo, Teresa; Margarit Ferrí, César; Rojo Rodríguez, Elena; Mendiola de la Osa, Agustín; Muñoz Martinez, Manuel José; Domínguez Bronchal, María Jesús; Herrero Trujillano, Manuel; Cid Calzada, José; Fabregat-Cid, Gustavo; Hernández-Cádiz, María José; Mareque Ortega, Manuel; Gómez-Caro Álvarez Palencia, Leticia; Mayoral Rojals, Víctor | ![](/image/openAccess.png) |
![Long-term deprescription in chronic pain and opioid use disorder patients. Pharmacogenetic and sex differences.pdf.jpg](/retrieve/442d251d-8781-4a09-b495-e3bbda10e4df/Long-term%20deprescription%20in%20chronic%20pain%20and%20opioid%20use%20disorder%20patients.%20Pharmacogenetic%20and%20sex%20differences.pdf.jpg) | 18-nov-2022 | Long-term deprescription in chronic pain and opioid use disorder patients: Pharmacogenetic and sex differences | Muriel, Javier; Escorial, Mónica; Margarit, César; Barrachina, Jordi; Carvajal, Cristian; Morales, Domingo; Peiró, Ana | ![](/image/openAccess.png) |
![Circulating miRNA-21 is an innovative biomarker for cardiovascular events in erectile dysfunction patients.pdf.jpg](/retrieve/39ae97c2-f354-4c4d-9ff6-5f81d21a0ee1/Circulating%20miRNA-21%20is%20an%20innovative%20biomarker%20for%20cardiovascular%20events%20in%20erectile%20dysfunction%20patients.pdf.jpg) | 21-mar-2024 | Circulating miRNA-21 is an innovative biomarker for cardiovascular events in erectile dysfunction patients | Agulló, Laura; Segura, Ana; Ortuño-Miquel, Samanta; Brinca, Ana Teresa; Micol-Ponce, Rosa; Arrarte, Vicente; Ponce, María Rosa; Miró-Martínez, Pau; Zandonai, Thomas; Peiró, Ana | ![](/image/openAccess.png) |
![Benzodiazepines in sport, an underestimated problem. Recommendations for sports medicine physicians’ practice.pdf.jpg](/retrieve/a8eb7ad0-a9db-4620-b281-1033b43f9322/Benzodiazepines%20in%20sport%2c%20an%20underestimated%20problem.%20Recommendations%20for%20sports%20medicine%20physicians%e2%80%99%20practice.pdf.jpg) | 21-dic-2022 | Benzodiazepines in sport, an underestimated problem: Recommendations for sports medicine physicians’ practice | Zandonai, Thomas; Peiró, Ana; FUSINA, FRANCESCA; Lugoboni, Fabio; Zamboni, Lorenzo | ![](/image/openAccess.png) |
![Pharmacogenetics May Prevent Psychotropic Adverse Events in Autism Spectrum Disorder. An Observational Pilot Study.pdf.jpg](/retrieve/8e029221-b410-4198-8f90-2cc542393bc7/Pharmacogenetics%20May%20Prevent%20Psychotropic%20Adverse%20Events%20in%20Autism%20Spectrum%20Disorder.%20An%20Observational%20Pilot%20Study.pdf.jpg) | 20-oct-2023 | Pharmacogenetics May Prevent Psychotropic Adverse Events in Autism Spectrum Disorder: An Observational Pilot Study | Miguel, Laura de; Ballester, Purificación; Egoavil, Cecilia; Sánchez-Ocaña, María Luisa; García-Muñoz, Ana María; Cerdá, Begoña; ZAFRILLA, PILAR; Ramos, Enrique; Peiró, Ana | ![](/image/openAccess.png) |
![Sex Differences in Oxycodone Naloxone vs. Tapentadol in Chronic Non-Cancer Pain. An Observational Real-World Study.pdf.jpg](/retrieve/a32f4d7a-81ff-4222-8a14-e364812dcd50/Sex%20Differences%20in%20Oxycodone%20Naloxone%20vs.%20Tapentadol%20in%20Chronic%20Non-Cancer%20Pain.%20An%20Observational%20Real-World%20Study.pdf.jpg) | 2-oct-2022 | Sex Differences in Oxycodone/Naloxone vs. Tapentadol in Chronic Non-Cancer Pain: An Observational Real-World Study | Barrachina, Jordi; Margarit, Cesar; Muriel, Javier; López Gil, Vicente; López Gil, Santiago; Ballester, Purificación; Mira-Lorente, Laura; Agulló, Laura; Peiró, Ana | ![](/image/openAccess.png) |